Patient-Centric Pharmacovigilance as a Future Priority
The Pharmacovigilance Market size is expanding as patient-centric approaches take center stage. Increasingly, patients are encouraged to report adverse drug reactions directly, using digital apps and mobile platforms.
This trend empowers patients, enhances transparency, and enriches safety databases with firsthand real-world accounts. Patient-centric pharmacovigilance also aligns with regulatory priorities, as health authorities emphasize the importance of diverse and direct patient-reported outcomes in decision-making.
In the future, the success of pharmacovigilance systems will depend not only on technological advancement but also on how effectively they integrate patient voices into drug safety monitoring, ensuring a more responsive and holistic approach to healthcare.